Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Immunocore, LLC recalls KIMMTRAK (tebentafusp-tebn) Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Subpotent Drug
Products
  • KIMMTRAK (tebentafusp-tebn) Injection
Company
Immunocore, LLC
Where it was sold

US Nationwide

Nationwide

Units affected
7,572 vials
About this recall
KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026